Global Market Insights add New Global Rapid Influenza Diagnostic Tests (RIDT) Market report provides in-depth information about market overview, top vendors, Key market highlights, product types, market drivers, challenges, trends, Rapid Influenza Diagnostic Tests (RIDT) industry landscape, size and forecast, five forces analysis, Key leading countries/Region.

The rapid influenza diagnostic tests (RIDT) market is expected to grow significantly by 2030 owing to increasing prevalence of influenza. In addition, surging necessity for early diagnosis, along with rising popularity of rapid testing, is set to further boost market growth through the forecast period.

Browse key industry insights spread across 80 pages with 69 market data tables & 12 figures & charts from the report, “Rapid Influenza Diagnostic Tests Market Size By End-use (Hospitals, Diagnostics Centers, Research Laboratories), Industry Analysis Report, Regional, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/rapid-influenza-diagnostic-tests-ridt-market

Notably, lack of skilled professionals and stringent lockdown regulations imposed during the COVID-19 outbreak posed a threat to market growth However, with the burgeoning number of cases and high risk of exposure to COVID-19 in hospital settings, at-home testing gained massive popularity. Thus, rising consumer interest in at-home testing kits, coupled with soaring demand for telemedicine for influenza infection diagnosis, has positively impacted the product landscape of the rapid influenza diagnostic tests (RIDT) market.

Furthermore, major players in the industry have been focusing on research and development activities to introduce technologically advanced rapid influenza tests. In addition, strategic partnerships and acquisitions have also aided in business expansion.

For instance, in October 2020, Quidel Corporation, a leading manufacturer of diagnostic healthcare products, received EUA (Emergency Use Authorization) from the U.S. FDA (Food and Drug Administration) for marketing its Sofia 2 Flu + SARS Antigen FIA, a rapid point-of-care test used in conjunction with Sofia 2 Fluorescent Immunoassay Analyzer to differentiate nucleocapsid protein antigen from SARS-CoV-2 and influenza A and B via direct nasal (NS) and nasopharyngeal (NP) swab samples in potential COVID-19 patients.

To cite another instance, in March 2021, Abbott, a multinational medical and healthcare devices company, introduced its Alinity m Resp-4-Plex assay that detects COVID-19, influenza A, influenza B, and RSV using only one swab. The innovation, which has received U.S. FDA Emergency Use Authorization, aims to reduce discomfort, and give an efficient four-in-one assay for quick diagnosis.

In another instance, in January 2021, Thermo Fisher Scientific, a prominent supplier in the rapid influenza diagnostic tests (RIDT) market, announced its plans to takeover molecular diagnostic expert Mesa Biotech. Mesa provides gold-standard nucleic acid PCR (polymerase chain reaction) amplification to point-of-care diagnostics for COVID-19, RSV, Influenza A and B, and Strep A.

Partial Table of Contents (ToC) of the report:
Chapter 4   Rapid Influenza Diagnostic Tests Market, By End-use
4.1    Key segment trends
4.2    Hospitals
4.2.1    Market size, by region, 2017 - 2030 (USD Million)
4.3    Diagnostics centers,
4.3.1    Market size, by region, 2017 - 2030 (USD Million)
4.4    Research laboratories
4.4.1    Market size, by region, 2017 - 2030 (USD Million)
4.5    Others
4.5.1    Market size, by region, 2017 - 2030 (USD Million)
Chapter 5   Rapid Influenza Diagnostic Tests Market, By Region
5.1    Key regional trends
5.2    North America
5.2.1    Market size, by country, 2017 - 2030 (USD Million)
5.2.2    Market size, by end-use, 2017 - 2030 (USD Million)
5.2.3    U.S.
5.2.3.1   Market size, by end-use, 2017 - 2030 (USD Million)
5.2.4    Canada
5.2.4.1   Market size, by end-use, 2017 - 2030 (USD Million)
5.3    Europe
5.3.1    Market size, by country, 2017 - 2030 (USD Million)
5.3.2    Market size, by end-use, 2017 - 2030 (USD Million)
5.3.3    Germany
5.3.3.1   Market size, by end-use, 2017 - 2030 (USD Million)
5.3.4    UK
5.3.4.1   Market size, by end-use, 2017 - 2030 (USD Million)
5.3.5    France
5.3.5.1   Market size, by end-use, 2017 - 2030 (USD Million)
5.3.6    Italy
5.3.6.1   Market size, by end-use, 2017 - 2030 (USD Million)
5.3.7    Spain
5.3.7.1   Market size, by end-use, 2017 - 2030 (USD Million)
5.4    Asia Pacific
5.4.1    Market size, by country, 2017 - 2030 (USD Million)
5.4.2    Market size, by end-use, 2017 - 2030 (USD Million)
5.4.3    China
5.4.3.1   Market size, by end-use, 2017 - 2030 (USD Million)
5.4.4    Japan
5.4.4.1   Market size, by end-use, 2017 - 2030 (USD Million)
5.4.5    India
5.4.5.1   Market size, by end-use, 2017 - 2030 (USD Million)
Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/rapid-influenza-diagnostic-tests-ridt-market
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us
Arun Hegde
Corporate Sales, USA
Global Market Insights Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com